Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 11 - 20 of about 72   

Articles published

CBST 61.66 +0.11 (0.18%)
price chart
Cubist to Present at August Investor Conference
LEXINGTON, Mass., Jul 28, 2014 (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that company management will discuss Cubist's business activities and financial outlook at investor conferences during August 2013.
Related articles »  
Top Decliners in Focus: Unisys Corporation (UIS), CONMED Corporation ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) fell more than 5 percent in the current trading session after JMP Securities lowered its ratings for the biopharmaceutical company from �Outperform� to �Market Perform� in a research report released on 23rd of July.
Stocks in the News�Zoetis (NYSE:ZTS), Keryx Biopharmaceuticals, (NASDAQ ...
Cubist Pharmaceuticals, Inc. (CBST) a biopharmaceutical company, is engaged in the research, development, and commercialization of pharmaceutical products for medical needs in the acute care environment in the United States.
Related articles »  
Hottest Healthcare Stocks Now � OMI HLS HAE TECH
Some of the biggest losers among healthcare stocks include: Align Technology (ALGN): ALGN stock is down 2.9% today. Cubist Pharmaceuticals (CBST): CBST stock is down 1.8% today. Acadia Pharmaceuticals Inc (ACAD): ACAD stock is down 1.7% today.
Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22 ...
LEXINGTON, Mass., Jul 15, 2014 (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) will issue its second quarter 2014 financial results at 4:00 p.m.
Related articles »  
First Week of CBST September 20th Options Trading
Investors in Cubist Pharmaceuticals Inc. (Symbol: CBST) saw new options begin trading this week, for the September 20th expiration.
Related articles »  
Alnylam to Host Additional Events in "RNAi Roundtable" Webcast Series
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has added three new events to its series of online "RNAi Roundtables" that it is hosting during July and August.
Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales - Analyst Blog
Apart from announcing its earnings results, Cubist Pharma reiterated the guidance for 2014 provided by it while releasing its fourth quarter and full year 2013 results in January.
Alnylam to Host Additional Events in �RNAi Roundtable� Webcast Series
CAMBRIDGE, Mass., Jul 29, 2014 (BUSINESS WIRE) -- Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) , a leading RNAi therapeutics company, today announced that it has added three new events to its series of online �RNAi Roundtables� that it is hosting during ...
Related articles »  
Cubist holds first ever volunteer day at charities around Boston
In a brief interview this morning, Bonney said that while the company has long focused on STEM education and matching gifts program, its recent growth has spurred a desire to do more.